PARP1 and posterior cortical atrophy: PARP inhibitors impair DNA repair via PARP enzyme blockade, inducing lethal DNA damage in homologous recombination repair (HRR)-deficient tumors (e.g., BRCA1/2-mutated PCa) (Wu et al., 2021).